Peter the Bridge, Saint Petersburg, Russia

EFFERVESCENCE 2019: NEOMED Institute will co-host a conference on SMEs financing

April 8th, 2019 |Announcement| No Comments

Montreal, Quebec, Canada, April 8th 2019– As part of this unique event, developed by a collective of 14 lead organizations in the LSHT (Life Sciences and Health Technologies) sector in Quebec, the NEOMED Institute will present the theme “Public-Private Collaborations: leverage for financing?” with the participation of the AmorChem II venture capital fund. The two groups invited some entrepreneurs to share their solutions to handling these financial issues.

During this session, moderated by Roberto Bellini, President and CEO of Bellus Health, you will discover the experience and financial challenges that have been faced:

  • Pascal Neuville, CEO of Domain Therapeutics
  • Frederic Leduc, President & CEO of Immune Biosolutions
  • Sarah Jenna, Co-founder & CEO of My Intelligent Machines
  • Etienne Lagacé, Co-founder & CEO of Moonshot Health
  • Sean McDonald, President & CEO of Corbin Therapeutics
  • Francois Ravenelle, Founder & CEO of Inversago

There is still time to register!

EFFERVESCENCE 2019 will be held on April 24 and 25 at La TOHU (Montreal).

Consult the full EFFERVESCENCE program 


For more information, please contact:

Shirley Robinet
Communications Coordinator, NEOMED Institute
(514) 375-3334 ext. 111

Share this

Similar News

image articles
30 May 2019

CDRD and NEOMED Institute Join Forces to Create a New Pan-Canadian Enterprise adMare BioInnovations

Read complete news
image articles
14 May 2019

Hope on the horizon for hard-to-treat breast cancers

Read complete news
© 2019 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia